文献速递术前评估与围术期医学疼痛医学

笑气对术后慢性疼痛的影响:ENIGMA-II试验12个月随访

Chronic postsurgical pain in the Evaluation of Nitrous Oxide in the Gas Mixture for Anaesthesia (ENIGMA)-II trial.
PubMed 文献 · Br J Anaesth · 2016-01-01

该研究对ENIGMA-II试验中2924例(41.1%)患者于术后12个月进行电话随访,评估笑气(一氧化氮)能否预防术后慢性疼痛。结果显示笑气总体未降低慢性术后疼痛发生率(11.8%对12.5%,RR 0.94,95%CI 0.75-1.17,P=0.57),但预设亚组分析中亚洲患者获益(RR 0.70,95%CI 0.50-0.98,P=0.031)。

要点

  • 笑气总体未降低术后12个月慢性疼痛风险
  • 亚洲患者亚组中笑气可能降低慢性术后疼痛风险
  • 两种MTHFR基因多态性纯合子接受笑气者慢性疼痛报告更少

核心结论

  • 笑气给药对术后慢性疼痛无总体影响,但在亚洲患者及携带亚甲基四氢叶酸还原酶基因变异者中仍可能存在获益。

研究设计与样本

  • 对ENIGMA-II试验中2924例(41.1%)患者于术后12个月进行电话随访。
  • 疼痛采用改良简明疼痛量表与神经病理性疼痛问卷记录,健康状态用EQ-5D问卷测量。
  • 在674例香港亚洲患者子集中进行基因分型(MTHFR 1298A>C、667C>T)。

主要发现

  • 术后12个月356例(12.2%)报告伤口部位慢性术后疼痛,112例(3.8%)为重度疼痛并需规律镇痛干预。
  • 笑气组慢性术后疼痛发生率为11.8%,无笑气组为12.5%,RR(95%CI)0.94(0.75-1.17),P=0.57。
  • 预设亚组分析中,亚洲患者接受笑气后慢性术后疼痛风险降低,RR(95%CI)0.70(0.50-0.98),P=0.031。
  • 两种基因多态性任一纯合子且术中接受笑气者,报告慢性术后疼痛的可能性更低。

临床怎么用

  • 笑气不宜作为普遍预防术后慢性疼痛的常规措施。
  • 对亚洲患者可结合个体情况权衡笑气的潜在长期镇痛获益。

局限性

  • 随访仅覆盖ENIGMA-II试验中2924例(41.1%)患者,存在失访偏倚可能。
  • 基因分型仅在674例香港亚洲患者子集中完成,样本有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous animal and clinical studies showed that nitrous oxide may produce long-term analgesia. The aim of this study was to evaluate the effect of nitrous oxide in preventing chronic postsurgical pain. We also explored whether methylenetetrahydrofolate reductase gene polymorphisms (1298A>C, 667C>T) would enhance nitrous oxide analgesia. METHODS: We conducted a telephone interview at 12 months after surgery on 2924 (41.1%) patients enrolled in the Evaluation of Nitrous Oxide in the Gas Mixture for Anaesthesia-II trial. Pain at the wound site was recorded using the modified brief pain inventory and the neuropathic pain questionnaire. General health status was measured using the EQ-5D questionnaire. Genotyping was performed in a subset of 674 Asian patients in Hong Kong. RESULTS: At 12 months after surgery, 356 (12.2%) patients reported chronic postsurgical pain at the wound site and 112 (3.8%) patients had severe pain and required regular analgesic interventions. Nitrous oxide did not affect the rate of chronic postsurgical pain (11.8% nitrous oxide group; 12.5% no nitrous oxide group), relative risk (95% confidence intervals): 0.94 (0.75-1.17), P=0.57. However, in a planned subgroup analysis, nitrous oxide reduced the risk of chronic postsurgical pain in Asian patients, relative risk (95% confidence intervals): 0.70 (0.50-0.98), P=0.031. Patients who were homozygous for either gene polymorphism and who received nitrous oxide during surgery were less likely to report chronic postsurgical pain. CONCLUSIONS: Nitrous oxide administration had no impact on chronic postsurgical pain, but benefits may still be possible in Asian patients and patients with variants in methylenetetrahydrofolate reductase gene. CLINICAL TRIAL REGISTRATION: NCT00430989.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Chan MT, Peyton PJ, Myles PS, et al. Chronic postsurgical pain in the Evaluation of Nitrous Oxide in the Gas Mixture for Anaesthesia (ENIGMA)-II trial. Br J Anaesth. 2016. PMID: 27956679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。